Article

2'-hydroxyflavanone inhibits proliferation, tumor vascularization and promotes normal differentiation in VHL-mutant renal cell carcinoma.

Department of Molecular Biology and Immunology, University of North Texas Health Science Center, Fort Worth, TX 76107, USA.
Carcinogenesis (Impact Factor: 5.27). 02/2011; 32(4):568-75. DOI: 10.1093/carcin/bgr021
Source: PubMed

ABSTRACT Renal cell carcinoma (RCC) is one of the top ten cancers prevalent in USA. Loss-of-function mutations in the von Hippel-Lindau (VHL) gene constitute an established risk factor contributing to 75% of total reported cases of RCC. Loss-of-VHL leads to a highly vascularized phenotype of renal tumors. Intake of citrus fruits has been proven to reduce the risk of RCC in multicenter international studies. Hence, we studied the effect of 2'-hydroxyflavanone (2HF), an active anticancer compound from oranges, in RCC. Our in vitro investigations revealed that 2HF suppresses VHL-mutant RCC to a significantly greater extent than VHL-wild-type RCC by inhibiting epidermal growth factor receptor signaling, which is increased due to VHL mutations in RCC. Our results also revealed for the first time, that 2HF inhibits glutathione S-transferase pi activity. 2HF reduced cyclin B1 and CDK4 levels and induced G2/M phase arrest in VHL-mutant RCC. Importantly, 2HF inhibited the angiogenesis in VHL-mutant RCC by decreasing vascular endothelial growth factor expression. Our in vivo studies in mice xenografts confirmed our in vitro results as evident by decreased levels of proliferation marker, Ki67 and angiogenic marker, CD31, in 2HF-treated mice xenografts of VHL-mutant RCC. 2HF also increased the expression of E-cadherin in VHL-mutant RCC, which would be of significance in restoring normal epithelial phenotype. Collectively, our in vitro and in vivo results revealed the potent antiproliferative, anti-angiogenic and prodifferentiation properties of 2HF in VHL-mutant RCC, sparing normal cells, which could have significant implications not only in the specific management of VHL-mutant RCC but also towards other VHL syndromes.

2 Followers
 · 
305 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Although there have been advances in therapeutic regimes for metastatic castration-resistant prostate cancer (CRPC), these recent developments have not led to improved cure rates. Thus, more novel agents to prolong patient survival are desired. 2'-Hydroxyflavanone (2HF), a nontoxic natural flavonoid, has been shown to exhibit pleiotropic anticancer effects in many cancer types, including prostate cancer (PCa). However, the therapeutic effects of 2HF on tumor growth and its potential mechanisms in CRPC have not been completely elucidated. In the present study, utilizing three different metastatic and androgen-independent PCa cell models (PC-3, DU145 and C4-2), we found that 2HF treatment not only resulted in inhibition of cell proliferation and colony formation in vitro, but also delayed subcutaneous tumor growth in vivo. Mechanistically, besides its known inhibitory effects on aldo‑keto reductase activity and de novo androgen synthesis, 2HF also markedly suppressed AKT phosphorylation, signal transducer and activator of transcription-3 (STAT3) phosphorylation and transactivation subsequently regulating the expression of members of the BCL-2 family (i.e., Mcl-1, Bcl-2 and Bax) and modulating caspase-mediated cell apoptosis. Overall, this study revealed a novel mechanism for 2HF targeting metastatic CRPC, in which inactivation of AKT/STAT3 signaling led to cell apoptosis and growth inhibition.
    Oncology Reports 05/2014; 32(1). DOI:10.3892/or.2014.3218 · 2.19 Impact Factor
  • Source
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Polyphenols are a large family of natural compounds widely distributed in plants and are the most studied chemopreventive agents. The biological activities and mechanism(s) of chemopreventive effects of polyphenols have been extensively studied. Therefore, this review focuses mainly on the evidence related to chemopreventive efficacy of polyphenols and describing their mechanism(s) of anti-initiating, anti-promoting and anti-progressor action(s) in different in vivo experimental systems. Studies employing in vivo experimental rodent models have demonstrated several polyphenols to modulate incidence, multiplicity, latency period of carcinogen-induced tumors at various organ sites and tumor angiogenesis, metastasis and behavior of transplanted tumors/xenografts. The observed in vivo anti-initiating, anti-promoting and anti-progressor activity of polyphenols in chemical and genetic models involve modulation of signaling kinases ultimately leading to effects on genes and cell signaling pathways at multiple levels. Overall, the mechanism(s) implicated in the polyphenol(s)-mediated inhibition are diverse and involve effects on multiple molecular pathways and genes.
    Polyphenols in Human Health and Disease, 2 edited by Ronald R. Watson, Victor R. Preedy, Sherma Zibadi, 01/2014: chapter Polyphenol(s)-mediated in vivo cellular responses during carcinogenesis: pages 1141-1179; Elsevier., ISBN: 978-0-12-398472-2

Full-text (2 Sources)

Download
76 Downloads
Available from
May 22, 2014